A systematic review and meta-analysis of obesity and COVID-19 outcomes

Abstract Some studies report that obesity is associated with more severe symptoms following SARS-CoV-2 infection and worse COVID-19 outcomes, however many other studies have not reproduced these findings. Therefore, it is uncertain whether obesity is in fact associated with worse COVID-19 outcomes c...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Xinya Zhang, Alexander M. Lewis, John R. Moley, Jonathan R. Brestoff
Formato:	article
Lenguaje:	EN
Publicado:	Nature Portfolio 2021
Materias:	Medicine R Science Q
Acceso en línea:	https://doaj.org/article/d338a59cfef64f3b9fa0b304d94fdcfa
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:d338a59cfef64f3b9fa0b304d94fdcfa
record_format	dspace
spelling	oai:doaj.org-article:d338a59cfef64f3b9fa0b304d94fdcfa2021-12-02T14:25:03ZA systematic review and meta-analysis of obesity and COVID-19 outcomes10.1038/s41598-021-86694-12045-2322https://doaj.org/article/d338a59cfef64f3b9fa0b304d94fdcfa2021-03-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-86694-1https://doaj.org/toc/2045-2322Abstract Some studies report that obesity is associated with more severe symptoms following SARS-CoV-2 infection and worse COVID-19 outcomes, however many other studies have not reproduced these findings. Therefore, it is uncertain whether obesity is in fact associated with worse COVID-19 outcomes compared to non-obese individuals. We conducted a systematic search of PubMed (including MEDLINE) and Google Scholar on May 18, 2020 to identify published studies on COVID-19 outcomes in non-obese and obese patients, covering studies published during the first 6 months of the pandemic. Meta-analyses with random effects modeling was used to determine unadjusted odds ratios (OR) and 95% confidence intervals (CI) for various COVID-19 outcomes in obese versus non-obese patients. By quantitative analyses of 22 studies from 7 countries in North America, Europe, and Asia, we found that obesity is associated with an increased likelihood of presenting with more severe COVID-19 symptoms (OR 3.03, 95% CI 1.45–6.28, P = 0.003; 4 studies, n = 974), developing acute respiratory distress syndrome (ARDS; OR 2.89, 95% CI 1.14–7.34, P = 0.025; 2 studies, n = 96), requiring hospitalization (OR 1.68, 95% CI 1.14–1.59, P < 0.001; 4 studies, n = 6611), being admitted to an intensive care unit (ICU; OR 1.35, 95% CI 1.15–1.65, P = 0.001; 9 studies, n = 5298), and undergoing invasive mechanical ventilation (IMV; OR 1.76, 95% CI 1.29–2.40, P < 0.001; 7 studies, n = 1558) compared to non-obese patients. However, obese patients had similar likelihoods of death from COVID-19 as non-obese patients (OR 0.96, 95% CI 0.74–1.25, P = 0.750; 9 studies, n = 20,597). Collectively, these data from the first 6 months of the pandemic suggested that obesity is associated with a more severe COVID-19 disease course but may not be associated with increased mortality.Xinya ZhangAlexander M. LewisJohn R. MoleyJonathan R. BrestoffNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-11 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	Medicine R Science Q
spellingShingle	Medicine R Science Q Xinya Zhang Alexander M. Lewis John R. Moley Jonathan R. Brestoff A systematic review and meta-analysis of obesity and COVID-19 outcomes
description	Abstract Some studies report that obesity is associated with more severe symptoms following SARS-CoV-2 infection and worse COVID-19 outcomes, however many other studies have not reproduced these findings. Therefore, it is uncertain whether obesity is in fact associated with worse COVID-19 outcomes compared to non-obese individuals. We conducted a systematic search of PubMed (including MEDLINE) and Google Scholar on May 18, 2020 to identify published studies on COVID-19 outcomes in non-obese and obese patients, covering studies published during the first 6 months of the pandemic. Meta-analyses with random effects modeling was used to determine unadjusted odds ratios (OR) and 95% confidence intervals (CI) for various COVID-19 outcomes in obese versus non-obese patients. By quantitative analyses of 22 studies from 7 countries in North America, Europe, and Asia, we found that obesity is associated with an increased likelihood of presenting with more severe COVID-19 symptoms (OR 3.03, 95% CI 1.45–6.28, P = 0.003; 4 studies, n = 974), developing acute respiratory distress syndrome (ARDS; OR 2.89, 95% CI 1.14–7.34, P = 0.025; 2 studies, n = 96), requiring hospitalization (OR 1.68, 95% CI 1.14–1.59, P < 0.001; 4 studies, n = 6611), being admitted to an intensive care unit (ICU; OR 1.35, 95% CI 1.15–1.65, P = 0.001; 9 studies, n = 5298), and undergoing invasive mechanical ventilation (IMV; OR 1.76, 95% CI 1.29–2.40, P < 0.001; 7 studies, n = 1558) compared to non-obese patients. However, obese patients had similar likelihoods of death from COVID-19 as non-obese patients (OR 0.96, 95% CI 0.74–1.25, P = 0.750; 9 studies, n = 20,597). Collectively, these data from the first 6 months of the pandemic suggested that obesity is associated with a more severe COVID-19 disease course but may not be associated with increased mortality.
format	article
author	Xinya Zhang Alexander M. Lewis John R. Moley Jonathan R. Brestoff
author_facet	Xinya Zhang Alexander M. Lewis John R. Moley Jonathan R. Brestoff
author_sort	Xinya Zhang
title	A systematic review and meta-analysis of obesity and COVID-19 outcomes
title_short	A systematic review and meta-analysis of obesity and COVID-19 outcomes
title_full	A systematic review and meta-analysis of obesity and COVID-19 outcomes
title_fullStr	A systematic review and meta-analysis of obesity and COVID-19 outcomes
title_full_unstemmed	A systematic review and meta-analysis of obesity and COVID-19 outcomes
title_sort	systematic review and meta-analysis of obesity and covid-19 outcomes
publisher	Nature Portfolio
publishDate	2021
url	https://doaj.org/article/d338a59cfef64f3b9fa0b304d94fdcfa
work_keys_str_mv	AT xinyazhang asystematicreviewandmetaanalysisofobesityandcovid19outcomes AT alexandermlewis asystematicreviewandmetaanalysisofobesityandcovid19outcomes AT johnrmoley asystematicreviewandmetaanalysisofobesityandcovid19outcomes AT jonathanrbrestoff asystematicreviewandmetaanalysisofobesityandcovid19outcomes AT xinyazhang systematicreviewandmetaanalysisofobesityandcovid19outcomes AT alexandermlewis systematicreviewandmetaanalysisofobesityandcovid19outcomes AT johnrmoley systematicreviewandmetaanalysisofobesityandcovid19outcomes AT jonathanrbrestoff systematicreviewandmetaanalysisofobesityandcovid19outcomes
_version_	1718391454252924928

A systematic review and meta-analysis of obesity and COVID-19 outcomes

Ejemplares similares